Clinical trial NCT03895580: Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk Reduction
Official title: Supermarket and Web-Based Intervention Targeting Nutrition (SuperWIN) for Cardiovascular Risk Reduction
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Obesity
Hypertension
Hyperlipidemias
Diet Modification
Lead sponsor: University of Cincinnati
Sponsor class: OTHER
Collaborators: name: The Kroger Company
name: Children's Hospital Medical Center, Cincinnati
First posted: 2019-03-29
Enrollment: 267
Sex: ALL
Minimum age (years): 21
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Due to COVID-19, recruitment and all in-person visits had to be temporarily stopped due to safety concerns in March 2020. Due to this stoppage, 20 randomized subjects could not complete their in-person study visits or data collection as per protocol. These 20 subjects will be excluded from all primary analyses, including the primary endpoint. Recruitment and in-person visits resumed in June 2020. To account for the exclusion of these 20 subjects, we randomized 267 subjects by the end of the study in order to have 247 subjects available for the primary analyses (e.g. 267-20= 247). A prespecified COVID impact analysis has been included in the statistical analysis plan.
Primary purpose: TREATMENT

Brief summary: The Supermarket and Web-based Intervention targeting Nutrition (SuperWIN) for cardiovascular risk reduction is a novel, randomized controlled trial aimed at increasing diet quality and decreasing cardiovascular risk. SuperWIN will deliver individualized, nutrition education at the point-of-purchase (POP), either in the aisles of the physical store or via online shopping platforms coupled with other modern software tools.

Detailed description: This study is designed to test whether individualized, POP nutrition education can improve dietary quality. The two interventions to be evaluated in SuperWIN will utilize either an in-store POP education strategy or a combined online/in-store POP education strategy in participants with at least one cardiovascular disease risk factor. The POP education interventions will be enhanced with sophisticated, provider- and participant-facing, food-purchasing metrics, a novel counseling tool that here-to-fore has not been studied in regard to changing food shopping behavior. The primary outcome measure is the Dietary Approaches to Stop Hypertension (DASH) score, a measure of adherence to the DASH dietary pattern. The study is well-powered to test at Day 90: 1) whether any POP education intervention strategy (both intervention arms pooled) improves the DASH score compared to the control arm and 2) whether an improvement in DASH score depends on the POP education strategy utilized.

Both POP education strategies will be delivered within a supermarket-based retail clinic and will utilize the aisles and products of the supermarket. The interventions will be delivered by a registered dietitian nutritionist (RDN). The online portion of the combined online/in-store education POP strategy will include online grocery shopping, online recipe resources, a grocery pickup or home delivery service, and a phone application to better select healthy foods.

Both strategies will be offered in addition to a "standard of care" medical nutrition therapy session. The DASH dietary pattern has been empirically tested and shown to favorably modify blood pressure, blood cholesterol, insulin sensitivity, and weight status.

Eligibility criteria: Inclusion Criteria:

1. Age ≥21 to ≤75 years on the start date of the study (Day 0)
2. Speak, write, read English fluently
3. In-person outpatient visit with a UC Health primary care network (PCN) provider within the last 12 months
4. Major food planner of their household, which may include planning, purchasing, and/or preparing greater than 50% of the meals or foods consumed at home
5. Existing shopper at a study site Kroger (≥50% of grocery store food dollars spent at Kroger) with a Kroger Loyalty ID number
6. Willing to use a new individual Kroger Loyalty ID number for the duration of the study
7. Access to a home desktop or laptop computer with reliable internet access
8. Access to an email account that can be used for the duration of the study
9. Able to independently purchase and prepare food:

   1. Reliable transportation to participating Kroger store
   2. Ability to stand for significant periods of time to grocery shop and prepare food at home
   3. Tools and equipment needed to prepare own food at home, such as a kitchen equipped with basic cooking tools (e.g. burner, pan, spatula, sink)
10. Presence of a cardiovascular risk factor(s) (at least one):

    1. Hypertension (defined by one of the following):

       * Blood pressure measurement: systolic blood pressure (SBP) 130-189 mm Hg and/or diastolic blood pressure (DBP) 80-109 mm Hg (at Visit #1)
       * Current treatment with an oral medication prescribed by a physician for blood pressure lowering (defined by one of the following):

         1. Beta blockers
         2. Diuretics (e.g. thiazide or thiazide-like diuretics, loop diuretics, aldosterone antagonists, potassium-sparing diuretics)
         3. Angiotensin-converting enzyme inhibitors
         4. Angiotensin II receptor blockers
         5. Direct renin inhibitors (i.e. aliskiren)
         6. Calcium channel blockers (dihydropyridine and nondihydropyridine)
         7. Calcium alpha2-agonist and other centrally acting drugs (e.g. clonidine)
         8. Direct vasodilators (e.g. hydralazine)
    2. Body-mass index (BMI) measurement ≥30 kg/m2 (at Visit #1)
    3. Hypercholesterolemia (defined by one of the following):

       * Low density lipoprotein cholesterol (LDL-C) 130-189 mg/dl (at Visit #1)
       * Current treatment with a medication prescribed by a physician for hypercholesterolemia (defined by one of the following):

         1. Statins
         2. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
         3. Absorption inhibitors (i.e. ezetimibe)
         4. Fibrates
         5. High-dose niacin (≥1 g per day)
         6. Bile acid sequestrants (e.g. cholestyramine)

Exclusion Criteria:

1. Unwillingness or inability to modify current diet
2. Actively engaged in another dietary intervention or taking a weight-loss supplement
3. SBP ≥190 mm Hg or DBP ≥110 mm Hg (at Visit #1)
4. Low-density lipoprotein cholesterol (LDL-C) ≥190 mg/dl, triglycerides (TG) ≥600 mg/dl, or glucose ≥400 mg/dl (at Visit #1)
5. Evidence of prior diagnosis of severe chronic kidney disease (CKD) defined by electronic health record codes for dialysis, CKD Stage 4 or 5 and/or last estimated glomerular filtration rate (eGFR) ≤30 ml/min/1.732 \[based on Modification of Diet in Renal Disease (MDRD) formula\]
6. Active cancer other than non-melanoma skin cancers (i.e. basal cell carcinoma or squamous cell carcinoma)
7. Diagnosis of celiac disease, ulcerative colitis, or Crohn's disease
8. High risk for alcohol use disorder:

   1. ≥21 drinks a week (men)
   2. ≥14 drinks a week (women)
9. Women who are pregnant or plan to become pregnant within the next 6 months from the start of the study (Day 0)
10. Food allergies requiring a specialized diet, including allergies to dairy products, eggs, peanuts, tree nuts, soy, gluten-containing wheat and grains, fish, and shellfish
11. Previous visit at TLC for diet counseling
12. Previous use of the Kroger's online shopping platform (Kroger.com or the Kroger app)
13. Participant lives greater than 20 miles from any participating Kroger study store (defined by zip codes)
14. Women, Infants, and Children (WIC) beneficiaries in their household

Primary outcomes:
measure: Change in Dietary Approaches to Stop Hypertension (DASH) score
timeFrame: Baseline with follow-up measures at 90 days and 180 days. Primary tests are between baseline and 90 day timepoint.
Secondary outcomes:
measure: Change in systolic arterial blood pressure
timeFrame: Baseline with follow-up measures at 90 days and 180 days.
measure: Change in diastolic arterial blood pressure
timeFrame: Baseline with follow-up measures at 90 days and 180 days.
measure: Change in body mass index
timeFrame: Baseline with follow-up measures at 90 days and 180 days.
measure: Change in non-high density lipoprotein cholesterol (Non-HDL-C)
timeFrame: Baseline with follow-up measures at 90 days and 180 days.
measure: Change in total cholesterol
timeFrame: Baseline with follow-up measures at 90 days and 180 days.
measure: Change in triglycerides
timeFrame: Baseline with follow-up measures at 90 days and 180 days.
Other outcomes:
measure: Change in waist circumference
timeFrame: Baseline with follow-up measures at 90 days and 180 days.
measure: Change in food literacy
timeFrame: Baseline with reassessment at 90 days.
measure: Participant experience and feedback
timeFrame: Collected at 90 days.
measure: Dietitian experience and feedback
timeFrame: Collected at 90 days.
Locations:
city: Cincinnati
country: United States
facility: University of Cincinnati Medical Center - UC Health
state: Ohio
Study officials:
affiliation: University of Cincinnati
name: Dylan L Steen, MD, MS
role: PRINCIPAL_INVESTIGATOR
affiliation: University of Cincinnati
name: Sarah C Couch, RD, PhD
role: PRINCIPAL_INVESTIGATOR
References: